Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

12,584 public trials 2,158 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Completed

A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

NCT03952559

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Instituto de Neumonología Y Dermatología Capital Federal, Buenos Aires, Argentina
  • Centro de Investigaciones Metabólicas (CINME) Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • Fundacion CIDEA Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina
  • Fundación Respirar Buenos Aires, Argentina
View all 78 locations
View Trial Details
Completed

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

NCT06467084

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • KalVista Investigative Site Birmingham, Alabama, United States
  • KalVista Investigative Site Scottsdale, Arizona, United States
  • KalVista Investigative Site San Diego, California, United States
  • KalVista Investigative Site Santa Monica, California, United States
View all 24 locations
View Trial Details
Completed

CryoBalloon Ablation for Treatment of Duodenal Adenomas

NCT03847636

Conditions
Adenoma, Adenomatous Polyposis Coli, Adenomatous Polyps, +18 more
Locations
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Northwell Health Manhasset, New York, United States
  • Geisinger Medical Center Danville, Pennsylvania, United States
  • Methodist Dallas Medical Center Dallas, Texas, United States
View Trial Details
Completed

Rate of Progression in EYS Related Retinal Degeneration

NCT04127006

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Colorado Retina Associates Denver, Colorado, United States
  • Vitreo-Retinal Associates Gainesville, Florida, United States
  • University of Miami: Neuro-ophthalmology Department Miami, Florida, United States
View all 19 locations
View Trial Details
Completed

A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

NCT05958407

Conditions
Atopic Dermatitis, Atopic Hand Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • LEO Pharma Investigational Site Birmingham, Alabama, United States
  • LEO Pharma Investigational Site Fort Smith, Arkansas, United States
  • LEO Pharma Investigational Site Fountain Valley, California, United States
  • LEO Pharma Investigational Site Los Angeles, California, United States
View all 69 locations
View Trial Details

Related conditions